Latest news
Replimune Group (REPL) Wins FDA Approval, Is The Valuation Still Too Rich? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 13:40:12 GMTRecovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA - MedCity NewsMedCity News · Fri, 07 Aug 2026 22:12:34 GMTReplimune's melanoma drug gets FDA nod but faces legal probe over data practices - PluangPluang · Fri, 07 Aug 2026 16:27:01 GMTReplimune to ride wave of physician support to launch advanced melanoma therapy - BioSpaceBioSpace · Fri, 07 Aug 2026 14:28:05 GMTThird time lucky for Replimune as FDA OKs melanoma drug - pharmaphorumpharmaphorum · Fri, 07 Aug 2026 09:50:13 GMTThird time’s the charm for Replimune as melanoma drug earns FDA greenlight - BioSpaceBioSpace · Thu, 06 Aug 2026 22:18:12 GMTIt’s Official: US FDA Approves Replimune’s Melanoma Drug - The Dermatology DigestThe Dermatology Digest · Thu, 06 Aug 2026 21:37:13 GMTUS FDA approves Replimune's skin cancer drug after prior rejections - ReutersReuters · Thu, 06 Aug 2026 21:30:41 GMT